Single-cell RNA sequencing, commonly known as single-cell RNA-seq or scRNA-seq, and single-nucleus RNA sequencing, often referred to as single-nucleus RNA-seq or snRNA-seq, both allow researchers to study gene expression at cell-level resolution. However, they start from different biological material. scRNA-seq profiles RNA from intact cells, while snRNA-seq profiles RNA from isolated nuclei.

The best choice is not simply a question of which workflow is better. It depends on sample type, tissue condition, dissociation feasibility, cell viability and the biological question. In this article, Novogene Europe explains key factors to consider when choosing between scRNA-seq and snRNA-seq.

What is the main difference?

In scRNA-seq, tissues or cell samples are prepared as a suspension of viable single cells before library preparation and sequencing. This can provide transcriptomic information from whole cells, including cytoplasmic RNA.

In snRNA-seq, nuclei are isolated instead of intact cells. This can be useful when whole-cell dissociation is difficult, when samples are frozen, or when certain cell types are fragile and may be lost during tissue dissociation.

Both approaches can reveal cell types, cell states and transcriptomic heterogeneity. However, the results may not be identical, because cells and nuclei contain different RNA populations and may recover different cell-type compositions.

When scRNA-seq may be preferred

scRNA-seq is often preferred when researchers have fresh, viable cells or tissues that can be dissociated into a high-quality single-cell suspension. It may be suitable for blood, immune cells, cell culture models, organoids or fresh tissues where dissociation can be well controlled.

Because the workflow captures RNA from intact cells, scRNA-seq may provide stronger information for some cytoplasmic transcripts and cell-state programmes. It can be especially useful when the research question focuses on immune profiling, treatment response, cellular activation or cell populations that can be recovered reliably as viable cells.

However, tissue dissociation can introduce bias. Some cells may be more fragile, more difficult to release, or more sensitive to enzymatic and mechanical handling. This means the final cell suspension may not perfectly represent the original tissue.

When snRNA-seq may be preferred

snRNA-seq can be a strong option for frozen tissues, archived samples, difficult-to-dissociate tissues or samples where intact cell recovery is challenging. It is often considered for solid tissues where preparing viable single-cell suspensions can be difficult.

Because nuclei can often be isolated from frozen material, snRNA-seq may provide more flexibility for sample collection, storage and batching. It can also help reduce some dissociation-related stress responses and may improve recovery of certain fragile or embedded cell types.

However, snRNA-seq is not simply a substitute for scRNA-seq. Nuclear RNA is enriched for pre-mRNA and intronic reads, and some cytoplasmic transcripts may be less represented. Data analysis and interpretation should take this into account.

Key factors to consider before choosing

A good workflow choice starts with the sample, not the technology name. Researchers should consider:

Sample condition: fresh, frozen, fixed or archived Tissue type: easy or difficult to dissociate Cell viability: expected live-cell recovery and sensitivity to handling Cell populations of interest: fragile, rare, immune, stromal or embedded cells Research question: cell composition, cell state, treatment response or cell-type-specific expression Practical workflow: collection timing, storage, transport and batching

For fresh samples with good viability and reliable dissociation, scRNA-seq may be appropriate. For frozen, fragile or difficult-to-dissociate samples, snRNA-seq may be more practical.

scRNA-seq and snRNA-seq data can differ

It is important to set expectations early. scRNA-seq and snRNA-seq can both generate valuable cell-level transcriptomic data, but they may differ in gene detection, cell-type recovery and biological signals.

For example, scRNA-seq may recover more suspension-like or immune cell populations in some samples, while snRNA-seq may better represent certain embedded or difficult-to-release cell types. These differences do not mean one method is always superior. They mean the workflow should match the biological question and sample reality.

Planning your project with Novogene Europe

At Novogene Europe, single-cell and single-nucleus transcriptomics projects can be reviewed based on sample type, tissue condition, viability expectations and downstream analysis goals. Early planning is especially important for dissociation strategy, nuclei isolation, cell or nuclei input, sequencing depth, batch design and data interpretation.

Choosing the right workflow helps researchers generate more reliable data and avoid common issues such as poor recovery, high debris, cell-type bias or results that do not match the original biological question.

FAQs

Is snRNA-seq better for frozen samples?

Often, yes. snRNA-seq is commonly considered for frozen or archived tissues because nuclei can often be isolated when intact viable cells are difficult to recover. Feasibility still depends on tissue type, storage condition and nuclei quality.

Is scRNA-seq better for fresh samples?

Often, but not always. Fresh samples with high viability and good dissociation performance are strong candidates for scRNA-seq. However, if the tissue is difficult to dissociate or contains fragile cell types, snRNA-seq may still be worth considering.

Can scRNA-seq and snRNA-seq give different results?

Yes. They may differ in cell-type composition, gene detection and RNA populations captured. This is expected because whole cells and nuclei are different biological inputs.

Which workflow is better for rare cell types?

It depends on the rare cell type and sample. Some fragile or embedded cell types may be better recovered using nuclei, while some immune or suspension-like populations may be better represented in single-cell suspensions.

Can Novogene Europe help choose the workflow?

Yes. Novogene Europe can review sample type, condition, expected cell or nuclei recovery and research goals to help assess whether scRNA-seq or snRNA-seq is more suitable.

References

1. Kim N et al. Perspectives on single-nucleus RNA sequencing. J Pathol Transl Med. 2023.
2. Renaut S et al. Single-cell and single-nucleus RNA-seq from paired lung samples. PLOS Genet. 2024.
3. 10x Genomics. Nuclei isolation for single-cell RNA sequencing. 2025.

Learn more

Planning a single-cell or single-nucleus RNA-seq project? Explore Novogene Europe’s single-cell transcriptomics services, review sample requirements, or contact our team to discuss the most suitable workflow for your sample type and research goals.